T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study.
Saved in:
| Title: | T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study. |
|---|---|
| Authors: | Wolf AS; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway. Electronic address: asia-sophia.wolf@fhi.no., Bjørlykke KH; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Ørbo HS; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Bhandari S; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Solum G; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Kjønstad IF; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Jyssum I; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Nygaard UC; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Kristoffersen AB; Division of Infection Control, Section for Modelling and Bioinformatics, Norwegian Institute of Public Health, Oslo, Norway., Christensen IE; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Josefsson SE; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway., Lund KP; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B Cell Malignancy, University of Oslo, Oslo, Norway., Chopra A; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway., Osen JR; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B Cell Malignancy, University of Oslo, Oslo, Norway., Chaban V; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B Cell Malignancy, University of Oslo, Oslo, Norway., Tveter AT; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway; Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway., Sexton J; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Kvien TK; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Jahnsen J; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Haavardsholm EA; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Grødeland G; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway., Vaage JT; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway., Provan SA; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway; Section for Public Health, Inland Norway University of Applied Sciences, Norway., Kared H; Department of Immunology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B Cell Malignancy, University of Oslo, Oslo, Norway., Lund-Johansen F; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway., Munthe LA; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B Cell Malignancy, University of Oslo, Oslo, Norway., Syversen SW; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway; Institute of Health and Society, University of Oslo, Norway., Goll GL; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway; Institute of Health and Society, University of Oslo, Norway., Jørgensen KK; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway. Electronic address: Kristin.Kaasen.Jorgensen@ahus.no., Mjaaland S; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway. |
| Source: | EBioMedicine [EBioMedicine] 2024 Oct; Vol. 108, pp. 105317. Date of Electronic Publication: 2024 Sep 10. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39260039 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wolf+AS%22">Wolf AS</searchLink>; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway. Electronic address: asia-sophia.wolf@fhi.no.<br /><searchLink fieldCode="AU" term="%22Bjørlykke+KH%22">Bjørlykke KH</searchLink>; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Ørbo+HS%22">Ørbo HS</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Bhandari+S%22">Bhandari S</searchLink>; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Solum+G%22">Solum G</searchLink>; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Kjønstad+IF%22">Kjønstad IF</searchLink>; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Jyssum+I%22">Jyssum I</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Nygaard+UC%22">Nygaard UC</searchLink>; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Kristoffersen+AB%22">Kristoffersen AB</searchLink>; Division of Infection Control, Section for Modelling and Bioinformatics, Norwegian Institute of Public Health, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Christensen+IE%22">Christensen IE</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Josefsson+SE%22">Josefsson SE</searchLink>; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Lund+KP%22">Lund KP</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B Cell Malignancy, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Chopra+A%22">Chopra A</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Osen+JR%22">Osen JR</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B Cell Malignancy, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Chaban+V%22">Chaban V</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B Cell Malignancy, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Tveter+AT%22">Tveter AT</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway; Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Sexton+J%22">Sexton J</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Kvien+TK%22">Kvien TK</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Jahnsen+J%22">Jahnsen J</searchLink>; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Haavardsholm+EA%22">Haavardsholm EA</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Grødeland+G%22">Grødeland G</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Vaage+JT%22">Vaage JT</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Provan+SA%22">Provan SA</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway; Section for Public Health, Inland Norway University of Applied Sciences, Norway.<br /><searchLink fieldCode="AU" term="%22Kared+H%22">Kared H</searchLink>; Department of Immunology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B Cell Malignancy, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Lund-Johansen+F%22">Lund-Johansen F</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Munthe+LA%22">Munthe LA</searchLink>; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Immunology, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for B Cell Malignancy, University of Oslo, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Syversen+SW%22">Syversen SW</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway; Institute of Health and Society, University of Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Goll+GL%22">Goll GL</searchLink>; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway; Institute of Health and Society, University of Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Jørgensen+KK%22">Jørgensen KK</searchLink>; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway. Electronic address: Kristin.Kaasen.Jorgensen@ahus.no.<br /><searchLink fieldCode="AU" term="%22Mjaaland+S%22">Mjaaland S</searchLink>; Division of Infection Control, Section for Immunology, Norwegian Institute of Public Health, Oslo, Norway. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101647039%22">EBioMedicine</searchLink> [EBioMedicine] 2024 Oct; Vol. 108, pp. 105317. <i>Date of Electronic Publication: </i>2024 Sep 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Observational Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101647039 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-3964 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223523964%22">23523964 </searchLink><i>NLM ISO Abbreviation: </i>EBioMedicine <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39260039 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ebiom.2024.105317 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 105317 Titles: – TitleFull: T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wolf AS – PersonEntity: Name: NameFull: Bjørlykke KH – PersonEntity: Name: NameFull: Ørbo HS – PersonEntity: Name: NameFull: Bhandari S – PersonEntity: Name: NameFull: Solum G – PersonEntity: Name: NameFull: Kjønstad IF – PersonEntity: Name: NameFull: Jyssum I – PersonEntity: Name: NameFull: Nygaard UC – PersonEntity: Name: NameFull: Kristoffersen AB – PersonEntity: Name: NameFull: Christensen IE – PersonEntity: Name: NameFull: Josefsson SE – PersonEntity: Name: NameFull: Lund KP – PersonEntity: Name: NameFull: Chopra A – PersonEntity: Name: NameFull: Osen JR – PersonEntity: Name: NameFull: Chaban V – PersonEntity: Name: NameFull: Tveter AT – PersonEntity: Name: NameFull: Sexton J – PersonEntity: Name: NameFull: Kvien TK – PersonEntity: Name: NameFull: Jahnsen J – PersonEntity: Name: NameFull: Haavardsholm EA – PersonEntity: Name: NameFull: Grødeland G – PersonEntity: Name: NameFull: Vaage JT – PersonEntity: Name: NameFull: Provan SA – PersonEntity: Name: NameFull: Kared H – PersonEntity: Name: NameFull: Lund-Johansen F – PersonEntity: Name: NameFull: Munthe LA – PersonEntity: Name: NameFull: Syversen SW – PersonEntity: Name: NameFull: Goll GL – PersonEntity: Name: NameFull: Jørgensen KK – PersonEntity: Name: NameFull: Mjaaland S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2024 Oct Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2352-3964 Numbering: – Type: volume Value: 108 Titles: – TitleFull: EBioMedicine Type: main |
| ResultId | 1 |